Physician profile
Peter Borek
NPI 1962176081
$763.05
in general payments reported to CMS, 2019-2025
11 companies · $24.86 in 2025
The $24.86 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.55 · 2022: $181 · 2023: $333 · 2024: $165 · 2025: $24.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $220.39 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $95.55 | 2023 | Fasenra |
| Philips North America LLC | $89.77 | 2023 | |
| Insmed, INC. | $89.00 | 2022 | |
| Inari Medical, INC. | $87.57 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Biotech, INC. | $49.30 | 2023-2024 | Tecvayli, Darzalex, Carvykti |
| Alexion Pharmaceuticals, INC. | $33.97 | 2024 | Ultomiris |
| Amgen INC. | $31.29 | 2023 | Tezspire |
| Abbott Laboratories | $24.86 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $21.81 | 2022 | |
| Medtronic, INC. | $19.54 | 2023 | Barrx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Borek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.